ZNF831 Inhibitors
ZNF831, also known as "Zinc Finger Protein 831," is a member of the zinc finger protein family, characterized by the presence of zinc finger domains that facilitate binding to DNA, RNA, or protein molecules. These domains consist of a zinc ion stabilized by cysteine and histidine residues, forming a finger-like loop that can interact with specific nucleotide sequences, thereby influencing the transcription of genes.The ZNF831 gene encodes a protein that is believed to function as a transcription factor, given its structural features that are common among proteins that regulate gene expression. Transcription factors are pivotal in turning genes on or off and are thus essential for proper cellular function and development.
The exact biological roles of ZNF831 are not fully characterized, but zinc finger proteins, in general, are involved in a variety of biological processes, including cell growth, differentiation, and apoptosis. They can act as activators or repressors of gene expression depending on the context of the cell type and the specific sequences they bind to within the genome. ZNF831 may also play a role in chromatin organization. Zinc finger proteins can contribute to the modification of chromatin structure, thereby affecting the accessibility of genes to the transcriptional machinery and influencing gene expression profiles.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could reduce methylation, potentially altering the expression of ZNF831 by affecting its promoter. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it may change chromatin structure and decrease ZNF831 expression by altering transcriptional activity. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
This compound intercalates into DNA, which could disrupt binding of ZNF831 to its target DNA sequences, indirectly inhibiting expression. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
By intercalating with DNA, it might prevent ZNF831 from binding to DNA, reducing its expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
It can chelate zinc ions, potentially disrupting zinc finger domains in ZNF831 and leading to loss of function and expression. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
This zinc chelator may disrupt the zinc finger structure of ZNF831, thus inhibiting its proper function and expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibiting the MAPK pathway, this compound might downregulate ZNF831 expression if it is regulated by this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting PI3K, it may alter transcription factor activity and potentially downregulate ZNF831 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
This drug binds to DNA and may inhibit the binding of transcription factors to GC-rich sequences, potentially reducing ZNF831 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
As a hypomethylating agent, it may alter gene expression patterns and could reduce the expression of ZNF831. | ||||||